Home
Conditions
Carcinoma, Medullary

Clinical trial condition

Carcinoma, Medullary

Explore clinical trials studying Carcinoma, Medullary. Study availability and eligibility vary by location and protocol.

103 public trials 12 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Medullary trial results

Completed

Clinicopathological Importance of Colorectal Medullary Carcinoma: Retrospective Cohort Study

NCT03774862

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +24 more
Locations: Not specified

View Trial Details

Completed

Assessing Quality of Life Tools in Medullary Thyroid Cancer Patients

NCT02465424

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
Locations: Velindre Hospital Cardiff, United Kingdom

University Hospitals of Coventry and Warwickshire Coventry, United Kingdom

Western general Hospital Edinburgh, United Kingdom

Imperial Hospital London, United Kingdom

View Trial Details

Completed

Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients

NCT01424878

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +20 more
Locations: National Cancer Institute (NCI), 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients

NCT02114658

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +16 more
Locations: Kobe, Hyōgo, Japan

Matsumoto, Nagano, Japan

Bunkyo-ku, Tokyo, Japan

Koto-ku, Tokyo, Japan

View Trial Details

Completed

Cinacalcet to Treat Familial Primary Hyperparathyroidism

NCT00325104

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +34 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study

NCT01927887

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +20 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Thalidomide in Treating Patients With Thyroid Cancer

NCT00026533

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +19 more
Locations: Albert B. Chandler Medical Center, University of Kentucky Lexington, Kentucky, United States

View Trial Details

Completed

Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy

NCT00095836

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +20 more
Locations: Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib

NCT01539655

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
Locations: Research Site Overland Park, Kansas, United States

View Trial Details

Completed

CAPRELSA® REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa®) in Current Clinical Practice

NCT02109250

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
Locations: Clinique du Sud Luxembourg Arlon, Belgium

AZ Klina Brasschaat, Belgium

Institut Jules Bordet Brussels, Belgium

UZ Brussel Brussels, Belgium

View Trial Details

Carcinoma, Medullary

Carcinoma, Medullary trial results

Related conditions